http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104792982-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54353 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-546 |
| filingDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104792982-B |
| titleOfInvention | A kind of aspirin Monitoring of drug resistance reagent |
| abstract | The invention discloses a kind of aspirin Monitoring of drug resistance reagent, belong to biological monitoring field.The monitoring reagent of the present invention is made up of reagent R1, reagent R2 and 11dhTxB2 reference standard product；Reagent R1 is by Tris, NaCl, BSA, Tween 20, PEG and NaN 3 Composition；Reagent R2 is by Tris, NaCl, BSA, Tween 20, NaN 3 , sucrose and 11dhTxB2 antibody sensitized latex Nano microsphere composition；11dhTxB2 reference standard product are by 11dhTxB2, Tris, NaCl, BSA, Tween 20, EDTA and NaN 3 Composition.Reagent accuracy of detection of the present invention is high, the range of linearity is wide and stability is high.It addition, antibody to be coated in microsphere surface, when antibody antigen in sample is combined, form antigen-antibody present latex particulate complex, add turbidity change, improve detection sensitivity. |
| priorityDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.